Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Plos Neglected Tropical Diseases|July 23, 2013
A single immunization with MVA expressing GnGc glycoproteins promotes epitope-specific CD8+-T cell activation and protects immune-competent mice against a lethal RVFV infectionElena López-Gil, Gema Lorenzo, Esther Hevia, et al.
Antiviral Research|March 20, 2017
Combined administration of synthetic RNA and a conventional vaccine improves immune responses and protection against foot-and-mouth disease virus in swineBelén Borrego, Esther Blanco, Miguel Rodríguez Pulido, et al.
The Journal of Infectious Diseases|November 17, 2005
Association between the infectivity of Mycobacterium tuberculosis strains and their efficiency for extrarespiratory infectionDario Garcia de Viedma, Gema Lorenzo, Pere-Joan Cardona, et al.
Antiviral Research|March 22, 2017
Microspheres-prime/rMVA-boost vaccination enhances humoral and cellular immune response in IFNAR(-/-) mice conferring protection against serotypes 1 and 4 of bluetongue virusAlejandro Marín-López, Eva Calvo-Pinilla, Diego Barriales, et al.
Vaccines|April 23, 2025
Prime-Boost Vaccination Based on Nanospheres and MVA Encoding the Nucleoprotein of Crimean-Congo Hemorrhagic Fever Virus Elicits Broad Immune ResponsesEva Calvo-Pinilla, Sandra Moreno, Natalia Barreiro-Piñeiro, et al.
Plos One|July 30, 2013
Ns1 is a key protein in the vaccine composition to protect Ifnar(-/-) mice against infection with multiple serotypes of African horse sickness virusFrancisco de la Poza, Eva Calvo-Pinilla, Elena López-Gil, et al.
Scientific Reports|November 24, 2020
A novel Schmallenberg virus subunit vaccine candidate protects IFNAR<sup>-/-</sup> mice against virulent SBV challengeHani Boshra, Gema Lorenzo, Diego Charro, et al.
Frontiers in Immunology|July 29, 2024
Co-expression of VP2, NS1 and NS2-Nt proteins by an MVA viral vector induces complete protection against bluetongue virusLuis Jiménez-Cabello, Sergio Utrilla-Trigo, Eva Calvo-Pinilla, et al.
NPJ Vaccines|August 15, 2020
A protective bivalent vaccine against Rift Valley fever and bluetongueEva Calvo-Pinilla, Alejandro Marín-López, Sandra Moreno, et al.
Viruses|January 23, 2024
Safety and Efficacy upon Infection in Sheep with Rift Valley Fever Virus ZH548-rA2, a Triple Mutant Rescued VirusSandra Moreno, Gema Lorenzo, Álvaro López-Valiñas, et al.
Pageof 4